Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study
- PMID: 29348155
- DOI: 10.1183/13993003.02369-2017
Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study
Conflict of interest statement
Conflict of interest: M. Sturm is a company director of Isopogen Pty Ltd; in addition, M. Sturm has a patent PCT/AU2014/001031 licensed (royalty free) to CTTWA. Y. Moodley has received honoraria for acting on scientific advisory boards from Boehringer Ingelheim and Roche, outside the submitted work.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical